510(k) Report

510(k) · Cleared

Cleared

Imaging system of positron emission and X-ray computed tomography (DigitMI 930)

K241266510(k) TraditionalCleared Jan 27, 2025266-day reviewClass II21 CFR 892.1200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Raysolution Healthcare Co., Ltd. · KPS System, Tomography, Computed, Emission

Cleared on Jan 27, 2025 as substantially equivalent to K161574 (Ge Medical Systems, LLC, 2016) after a 266-day review. Its family tree reaches back 8 generations to 2001.

Decided
Jan 27, 2025
Review
266 days
Class
Class II
Product code
KPS
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K010641 (2001). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 8 generations backK010641 GE CT-Pet SystemGe Medical Systems, Inc. · 2001
  2. 7 generations backK023988 GE Discovery LS SystemGE Medical Systems · 2003 · Recalled
  3. 6 generations backK040172 Modification to GE Discovery LS SystemGE Medical Systems · 2004 · Recalled
  4. 5 generations backK041543 GE Discovery STGE Healthcare · 2004 · Recalled
  5. 4 generations backK050559 GE Discovery VCT SystemGE Medical Systems · 2005 · Recalled
  6. 3 generations backK081496 Optima Pet/CT 560Ge Medical Systems, LLC · 2008 · Recalled
  7. 2 generations backK133657 Discovery Pet/CT 710Ge Medical Systems, LLC · 2014 · Recalled
  8. 1 generation backK161574 Discovery MIGe Medical Systems, LLC · 2016 · Recalled
  9. This deviceK241266 Imaging system of positron emission and X-ray computed tomography…Raysolution Healthcare Co., Ltd. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K010641GE CT-Pet SystemGe Medical Systems, Inc.2001—
−7K023988GE Discovery LS SystemGE Medical Systems20031
−6K040172Modification to GE Discovery LS SystemGE Medical Systems20045
−5K041543GE Discovery STGE Healthcare20041
−4K050559GE Discovery VCT SystemGE Medical Systems20051
−3K081496Optima Pet/CT 560Ge Medical Systems, LLC20087
−2K133657Discovery Pet/CT 710Ge Medical Systems, LLC20144
−1K161574Discovery MIGe Medical Systems, LLC20163
0 (this device)K241266Imaging system of positron emission and X-ray computed tomography (DigitMI 930)Raysolution Healthcare Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
200410
FIG. 1 — Lineage of K241266, 2001–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPS device

  1. #1 K253564 uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI…score 18.6 · 17 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161574Discovery MI
Summary page 8
…e PET part consists of a 72 ring LYSO detector, while the CT part has 64 physical rows of detectors. Predicate Device Identification Predicate Device: 510(k) Number: K161574 Product Name: Discovery MI Manufacturer: GE Medical Systems, L.L.C. Non-Clinical Test Conclusion Non clinical tests were conduc…
Ge Medical Systems, LLC20163

Also cleared against K161574: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 5 companies; a new generation was cleared every 2.4 years on median.
  • 8 of the 10 ancestors have a recall of any class.
  • 1 other device also cites its predicate K161574.

How does its category compare?

All KPS devices

KPS System, Tomography, Computed, Emission: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · KPS

12in 2025

2007: 82008: 172009: 92010: 32011: 72012: 62013: 112014: 112015: 32016: 112017: 112018: 132019: 32020: 122021: 152022: 52023: 122024: 112025: 122026 (partial year): 6
2007high 17 (2008) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPS

65in 2025

2007: 38 days median2008: 25 days median2009: 42 days median2010: 91 days median2011: 28 days median2012: 94 days median2013: 84 days median2014: 92 days median2015: 112 days median2016: 65 days median2017: 104 days median2018: 59 days median2019: 60 days median2020: 72 days median2021: 66 days median2022: 60 days median2023: 63 days median2024: 59 days median2025: 65 days median2026 (partial year): 67 days median
2007high 112 (2015) · low 25 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPS

16in 2025

2007: 222008: 162009: 142010: 42011: 342012: 132013: 132014: 182015: 52016: 162017: 112018: 12, 3 Class I2019: 5, 5 Class I2020: 82021: 42022: 8, 6 Class I2023: 6, 3 Class I2024: 152025: 162026 (partial year): 6
2007high 34 (2011) · low 4 (2010)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · KPS

36in 2025

2007: 382008: 112009: 152010: 442011: 562012: 342013: 2402014: 332015: 242016: 102017: 312018: 262019: 1052020: 222021: 102022: 152023: 222024: 232025: 36
2007high 240 (2013) · low 10 (2016)2025

MAUDE reports naming product code KPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078382238
200817251611
20099421415
2010391444
20117283456
20126941334
2013118413240
201411921833
20153112524
201611651610
2017111041131
2018135912 (3)26
20193605 (5)105
20201272822
20211566410
20225608 (6)15
202312636 (3)22
202411591523
202512651636
20266676—

What is it indicated for?

The Imaging system of positron emission and X-ray computed tomography is a PET/CT system for producing attenuation corrected PET images. It is intended to be used by qualified health care professionals for imaging the distribution and localization of any positron-emitting radiopharmaceutical in a patient, for the assessment of metabolic (molecular) and physiologic function in patients, with a wide range of sizes and extent of disease, of all ages.…

Read the full statement (301 words)

The Imaging system of positron emission and X-ray computed tomography is a PET/CT system for producing attenuation corrected PET images. It is intended to be used by qualified health care professionals for imaging the distribution and localization of any positron-emitting radiopharmaceutical in a patient, for the assessment of metabolic (molecular) and physiologic function in patients, with a wide range of sizes and extent of disease, of all ages.

Imaging system of positron emission and X-ray computed tomography is intended to image the whole body, head, heart, brain, lung, breast, bone, the gastrointestinal and lymphatic systems, and other organs. The images produced by the system may be used by physicians to aid in radiotherapy treatment planning, therapy guidance and monitoring, and in interventional radiology procedures. The images may also be used for precise functional and anatomical mapping (localization, registration, and fusion).

When used with radiopharmaceuticals approved by the regulatory authority in the country of use, the raw and image data is an aid in; detection, localization, evaluation, diagnosis, staging, restaging, monitoring, and/or follow up, of abnormalities, lesions, tumors, inflammation, infection, organ function, disorders, and/or disease, such as, but not limited to, those in oncology, cardiology, and neurology. Examples of which are:

Cardiology:

Cardiovascular disease

Myocardial perfusion

Myocardial viability

Cardiac inflammation

Coronary artery disease

Neurology:

Epilepsy

Dementia, such as Alzheimer's disease, Lewy body dementia, Parkinson's disease with dementia, and frontotemporal dementia.

Movement disorders, such as Parkinson's and Huntington's disease

Tumors

Inflammation

Cerebrovascular disease such as acute stroke, chronic and acute ischemia

Traumatic Brain Injury (TBI)

Oncology/Cancer:

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Breast Cancer

Prostate Cancer

Hodgkin disease

Non-Hodgkin lymphoma

Colorectal Cancer

Melanoma

Imaging system of positron emission and X-ray computed tomography is also intended for stand-alone, diagnostic CT imaging in accordance with the stand-alone CT system's cleared indications for use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K241266: Imaging system of positron emission and X-ray computed tomography (DigitMI 930).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241266

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026